# Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

> **NCT07292298** · PHASE2 · RECRUITING · sponsor: **University of Colorado, Denver** · enrollment: 44 (estimated)

## Conditions studied

- Rectal Adenocarcinoma
- Rectal Cancer

## Interventions

- **RADIATION:** High Rare Dose Rectal Brachytherapy Boost

## Key facts

- **NCT ID:** NCT07292298
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-11
- **Primary completion:** 2030-11
- **Final completion:** 2031-11
- **Target enrollment:** 44 (ESTIMATED)
- **Last updated:** 2026-04-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07292298

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07292298, "Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07292298. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*